WHO ICTRP trial
A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune…
CTIS2025-521692-31-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2025-521692-31-00 |
|---|---|
| Public title | A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia |
| Scientific title | A Phase 3, Open-label, Multicenter Continuation Trial to Evaluate the Long-term Safety and Efficacy of Mezagitamab Subcutaneous Injection in Adults with Chronic Primary Immune Thrombocytopenia - TAK-079-3003 |
| Primary sponsor | Takeda Development Center Americas Inc. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No |
| Countries | China;United States;Australia;Hong Kong;Turkey;United Kingdom;Japan;Korea, Republic of;Bulgaria;Spain;Netherlands;Italy;Poland |
| Conditions | Chronic Primary Immune Thrombocytopenia MedDRA version: 23.0Level: LLTClassification code: 10083843Term: Primary immune thrombocytopenia Class: 10005329;Therapeutic area: Diseases [C] - Hemic and Lymphatic Diseases [C15] |
| Interventions | Product Name: Mezagitamab, Product Code:PRD10973342, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: |
| Registration date | Jul 14, 2025 |
| Target size | 130 |
| Secondary IDs | NCT06948318 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: